Veterinary Infectious Disease Diagnostics Market – Ready to Experience Exponential Growth by 2030

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Veterinary Infectious Disease Diagnostics Market

Increased pet ownership, the rise in animal health spending, and the demand for pet insurance are driving the global market for the diagnosis of infectious diseases in animals. “

– Allied market research

PORTLAND, OR, UNITED STATES, Oct 25, 2021 / – The rise in pet ownership, the rise in animal health spending, and the demand for pet insurance are fueling the global veterinary infectious disease diagnosis market. However, the lack of veterinary infrastructure in underdeveloped countries is hindering market growth. On the other hand, the global awareness of animal health creates new opportunities in the years to come.

“Veterinary Infectious Disease Diagnostics Market by Product Type (Immunodiagnostics, Molecular Diagnostics, and Others) and Application (Dogs, Cats, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026.” According to the report, the global infectious disease veterinary diagnostics industry in 2018 generated 1, $ 27 billion and is valued at $ 2.40 billion by 2026, which has grown at an annual growth rate of 8.3% from 2019 to 2026.

Browse Description of Report @

The immunodiagnostics segment is expected to maintain its leadership position until 2026

Based on product type, the Immunodiagnostics segment contributed nearly half of the total share of the global Veterinary Infectious Disease Diagnostics market in 2018 and is expected to maintain its leading position throughout the forecast period. Additionally, this segment would have the highest CAGR of 9.2% from 2019 to 2026. This is due to the benefits associated with using these tests, including quick results and accurate diagnosis. The research also analyzes segments such as molecular diagnostics and others.

The dog segment is expected to keep its lion’s share of sales until 2026

By application, the dogs segment had the largest market share in the global infectious disease veterinary diagnosis market in 2026 with more than two fifths of the total market share in 2018. In addition, this segment will grow from 2019 to 2026 with the highest CAGR of 9.0%. This is due to the worldwide increase in the ownership of dogs as companion animals. The report also discusses segments such as cats and others.

North America is expected to maintain its dominance in the forecast period

Based on the region, North America had the highest market share in terms of revenue, which accounted for nearly two-fifths of the global veterinary infectious disease diagnosis market in 2018 and is expected to maintain its dominance over the forecast period. This is attributed to increased awareness of early pet disease screening and the availability of better veterinary treatment options, and the Asia-Pacific region is expected to hold the highest CAGR of 10.3% from 2019 to 2026 due to the increase pet ownership and raising awareness of the early diagnosis and treatment of diseases that occur in pets.

For purchase inquiries at:

Leading Market Players: –

Key players in the market include Biomérieux SA, HESKA Corporation, IDEXX Laboratories, Inc., ID.Vet, Neogen Corporation, Qiagen NV, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac and Zoetis.

Avenue Basic Plan | Library access | 1 year subscription |

Sign up for an Avenue subscription to access 12,000+ company profiles and 2,000+ niche market research reports for $ 699 per month per seat. The customer must purchase at least 2 seats for one year.

Request a 14-day free trial:

“We have also published some syndicated market research in a similar area that may be of interest to you. Below is the report title for your reference considering the impact of Covid-19 on this market that will help you assess the aftermath of the pandemic on the short and long term growth trends of this market. “

Trend reports in the healthcare industry:

Global Trenbolone Enanthate Market Research Till 2030

Global Breast Implants Market Research Till 2030

Global Platelet Rich Plasma Market Research Till 2030

About us:

Allied Market Research (AMR) is a full-service market research and management consulting arm of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides unmatched quality of “Market Research Reports” and “Business Intelligence Solutions” to global corporations as well as medium and small businesses. AMR provides focused business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas.

Allied Market Research CEO Pawan Kumar leads the company to deliver high quality data and insights. We have professional business relationships with various companies and this helps us unearth market data which will help us create accurate research data tables and confirm the highest accuracy of our market forecasts. All of the data presented in the reports we publish are extracted through primary interviews with top officials from leading companies in the domain in question. Our methodology for obtaining secondary data includes in-depth online and offline research and discussions with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+1 8007925285 extension
email us here
Visit us on social media:

You just read:

News provided by

October 25, 2021 at 6:02 pm GMT

EIN Presswire’s priority is source transparency. We don’t allow opaque clients, and our editors try to carefully weed out false and misleading content. If, as a user, you see something that we have overlooked, please make us aware of it. Your help is welcome. ONE Presswire, Everyone’s Internet News Presswire ™, seeks to define some of the boundaries that are appropriate in the world today. Please see our editorial guidelines for more information.

Submit your press release